Literature DB >> 24642426

Limitations of Foxp3(+) Treg depletion following viral infection in DEREG mice.

Allison F Christiaansen1, Paola M Boggiatto1, Steven M Varga2.   

Abstract

Regulatory T cells (Tregs) play a critical role in maintaining tissue homeostasis and preventing the development of immunopathology. Depletion of REGulatory T cell (DEREG) mice express a diphtheria toxin receptor (DTR)-eGFP transgene under the control of the Foxp3 promoter allowing for Treg depletion following diphtheria toxin (DT) administration. DEREG mice have been utilized to investigate the role of Tregs in a wide range of disease settings. Administration of DT to naïve DEREG mice resulted in the rapid depletion of Foxp3(+) Tregs from the peripheral blood. However, by day 4 post-DT administration, a GFP(-) Foxp3(+) Treg population emerged that lacked expression of the DTR transgene and was resistant to further depletion by additional DT treatment. We further evaluated the impact of Treg depletion during both acute and chronic viral infections. Similar to naïve mice, Treg numbers rapidly rebounded during an inflammatory setting following an acute viral infection. DT treatment of both wild-type (WT) and DEREG mice following both acute and chronic viral infections induced exacerbated disease as compared to PBS-treated controls. Furthermore, following a chronic systemic viral infection, DT treatment resulted in nearly 100% mortality in both WT and DEREG mice while the PBS-treated controls survived. Our results demonstrate that Treg depletion in DEREG mice is transient and that DT administration can have adverse effects during virus-induced inflammation and highlights the critical need to include DT-treated WT mice when using DTR models to control for DT-mediated toxicity.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Lung; Regulatory T cell; Spleen; T cell; Viral

Mesh:

Substances:

Year:  2014        PMID: 24642426      PMCID: PMC4029878          DOI: 10.1016/j.jim.2014.03.005

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  30 in total

1.  The temporal and spatial dynamics of Foxp3+ Treg cell-mediated suppression during contact hypersensitivity responses in a murine model.

Authors:  Sari Lehtimäki; Terhi Savinko; Katharina Lahl; Tim Sparwasser; Henrik Wolff; Antti Lauerma; Harri Alenius; Nanna Fyhrquist
Journal:  J Invest Dermatol       Date:  2012-06-28       Impact factor: 8.551

2.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.

Authors:  C L Bennett; J Christie; F Ramsdell; M E Brunkow; P J Ferguson; L Whitesell; T E Kelly; F T Saulsbury; P F Chance; H D Ochs
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

3.  Transient Foxp3(+) regulatory T-cell depletion enhances therapeutic anticancer vaccination targeting the immune-stimulatory properties of NKT cells.

Authors:  Stephen R Mattarollo; Kim Steegh; Ming Li; Helene Duret; Shin Foong Ngiow; Mark J Smyth
Journal:  Immunol Cell Biol       Date:  2012-10-23       Impact factor: 5.126

4.  Impairment of podocyte function by diphtheria toxin--a new reversible proteinuria model in mice.

Authors:  Andreas Goldwich; Alexander Steinkasserer; André Gessner; Kerstin Amann
Journal:  Lab Invest       Date:  2012-09-24       Impact factor: 5.662

5.  On the role of regulatory T cells during viral-induced inflammatory lesions.

Authors:  Tamara Veiga-Parga; Amol Suryawanshi; Sachin Mulik; Fernanda Giménez; Shalini Sharma; Tim Sparwasser; Barry T Rouse
Journal:  J Immunol       Date:  2012-11-05       Impact factor: 5.422

6.  Vagaries of fluorochrome reporter gene expression in Foxp3+ regulatory T cells.

Authors:  Sonja Schallenberg; Cathleen Petzold; Pei-Yun Tsai; Tim Sparwasser; Karsten Kretschmer
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

7.  Tumor-specific CD4+ T cells develop cytotoxic activity and eliminate virus-induced tumor cells in the absence of regulatory T cells.

Authors:  Ilseyar Akhmetzyanova; Gennadiy Zelinskyy; Simone Schimmer; Sven Brandau; Petra Altenhoff; Tim Sparwasser; Ulf Dittmer
Journal:  Cancer Immunol Immunother       Date:  2012-08-14       Impact factor: 6.968

8.  IL-21 restricts virus-driven Treg cell expansion in chronic LCMV infection.

Authors:  Iwana Schmitz; Christoph Schneider; Anja Fröhlich; Helge Frebel; Daniel Christ; Warren J Leonard; Tim Sparwasser; Annette Oxenius; Stefan Freigang; Manfred Kopf
Journal:  PLoS Pathog       Date:  2013-05-16       Impact factor: 6.823

9.  Absence of Foxp3+ regulatory T cells during allergen provocation does not exacerbate murine allergic airway inflammation.

Authors:  Abdul Mannan Baru; Venkateswaran Ganesh; Jayendra Kumar Krishnaswamy; Christina Hesse; Christopher Untucht; Silke Glage; Georg Behrens; Christian Thomas Mayer; Franz Puttur; Tim Sparwasser
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

10.  Regulatory T cells prevent Th2 immune responses and pulmonary eosinophilia during respiratory syncytial virus infection in mice.

Authors:  Lydia R Durant; Spyridon Makris; Cornelia Maaike Voorburg; Jens Loebbermann; Cecilia Johansson; Peter J M Openshaw
Journal:  J Virol       Date:  2013-08-07       Impact factor: 5.103

View more
  24 in total

1.  Altered Treg and cytokine responses in RSV-infected infants.

Authors:  Allison F Christiaansen; Muhammad A Syed; Patrick P Ten Eyck; Stacey M Hartwig; Lakshmi Durairaj; Sameer S Kamath; Steven M Varga
Journal:  Pediatr Res       Date:  2016-06-21       Impact factor: 3.756

2.  Cre-inducible human CD59 mediates rapid cell ablation after intermedilysin administration.

Authors:  Dechun Feng; Shen Dai; Fengming Liu; Yosuke Ohtake; Zhou Zhou; Hua Wang; Yonggang Zhang; Alison Kearns; Xiao Peng; Faliang Zhu; Umar Hayat; Man Li; Yong He; Mingjiang Xu; Chunling Zhao; Min Cheng; Lining Zhang; Hong Wang; Xiaofeng Yang; Cynthia Ju; Elizabeth C Bryda; Jennifer Gordon; Kamel Khalili; Wenhui Hu; Shuxin Li; Xuebin Qin; Bin Gao
Journal:  J Clin Invest       Date:  2016-05-09       Impact factor: 14.808

3.  T Regulatory Cells Support Plasma Cell Populations in the Bone Marrow.

Authors:  Arielle Glatman Zaretsky; Christoph Konradt; Fabien Dépis; James B Wing; Radhika Goenka; Daniela Gomez Atria; Jonathan S Silver; Sunglim Cho; Amaya I Wolf; William J Quinn; Julie B Engiles; Dorothy C Brown; Daniel Beiting; Jan Erikson; David Allman; Michael P Cancro; Shimon Sakaguchi; Li-Fan Lu; Christophe O Benoist; Christopher A Hunter
Journal:  Cell Rep       Date:  2017-02-21       Impact factor: 9.423

4.  Regulatory T-cells promote pulmonary repair by modulating T helper cell immune responses in lipopolysaccharide-induced acute respiratory distress syndrome.

Authors:  Wen Tan; Chaoji Zhang; Jianzhou Liu; Qi Miao
Journal:  Immunology       Date:  2019-05-06       Impact factor: 7.397

5.  Intein-mediated cytoplasmic reconstitution of a split toxin enables selective cell ablation in mixed populations and tumor xenografts.

Authors:  Vedud Purde; Elena Kudryashova; David B Heisler; Reena Shakya; Dmitri S Kudryashov
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-24       Impact factor: 11.205

6.  The immunotherapeutic role of regulatory T cells in Leishmania (Viannia) panamensis infection.

Authors:  Allison Ehrlich; Tiago Moreno Castilho; Karen Goldsmith-Pestana; Wook-Jin Chae; Alfred L M Bothwell; Tim Sparwasser; Diane McMahon-Pratt
Journal:  J Immunol       Date:  2014-08-06       Impact factor: 5.422

Review 7.  The Immune Fulcrum: Regulatory T Cells Tip the Balance Between Pro- and Anti-inflammatory Outcomes upon Infection.

Authors:  Laura E Richert-Spuhler; Jennifer M Lund
Journal:  Prog Mol Biol Transl Sci       Date:  2015-08-18       Impact factor: 3.622

8.  Regulatory T Cells Contribute to Resistance against Lyme Arthritis.

Authors:  Emily M Siebers; Elizabeth S Liedhegner; Michael W Lawlor; Ronald F Schell; Dean T Nardelli
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441

9.  CD4+ Regulatory T Cells Exert Differential Functions during Early and Late Stages of the Immune Response to Respiratory Viruses.

Authors:  Meredith C Rogers; Kristina D Lamens; Nazly Shafagati; Monika Johnson; Tim D Oury; Sebastian Joyce; John V Williams
Journal:  J Immunol       Date:  2018-07-11       Impact factor: 5.422

Review 10.  Versatile cell ablation tools and their applications to study loss of cell functions.

Authors:  Fengming Liu; Shen Dai; Dechun Feng; Xiao Peng; Zhongnan Qin; Alison C Kearns; Wenfei Huang; Yong Chen; Süleyman Ergün; Hong Wang; Jay Rappaport; Elizabeth C Bryda; Anand Chandrasekhar; Bertal Aktas; Hongzhen Hu; Sulie L Chang; Bin Gao; Xuebin Qin
Journal:  Cell Mol Life Sci       Date:  2019-07-29       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.